EP0603393A4 - Interleukine 6 humaine de recombinaison avec terminaison n homogene et production de cette interleukine. - Google Patents

Interleukine 6 humaine de recombinaison avec terminaison n homogene et production de cette interleukine.

Info

Publication number: EP0603393A4
Authority: EP; European Patent Office
Prior art keywords: interleukin; homogeneous; terminus; termination; production
Prior art date: 1991-07-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP92914381A

Other languages

German (de)

English (en)

Other versions

EP0603393A1 (fr

Inventor

Masakazu Chugai Seiya Hasegawa

Tetsuro Chugai Seiyaku K Orita

Norimichi Chugai Seiyaku Ochi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Chugai Pharmaceutical Co Ltd

Original Assignee

Chugai Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-07-08

Filing date

1992-07-06

Publication date

1995-03-29

1992-07-06 Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd

1994-06-29 Publication of EP0603393A1 publication Critical patent/EP0603393A1/fr

1995-03-29 Publication of EP0603393A4 publication Critical patent/EP0603393A4/fr

Status Withdrawn legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5412—IL-6
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

EP92914381A 1991-07-08 1992-07-06 Interleukine 6 humaine de recombinaison avec terminaison n homogene et production de cette interleukine. Withdrawn EP0603393A4 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP167095/91		1991-07-08
JP16709591		1991-07-08
PCT/JP1992/000849 WO1993001214A1 (fr)	1991-07-08	1992-07-06	Interleukine 6 humaine de recombinaison avec terminaison n homogene et production de cette interleukine

Publications (2)

Publication Number	Publication Date
EP0603393A1 EP0603393A1 (fr)	1994-06-29
EP0603393A4 true EP0603393A4 (fr)	1995-03-29

Family

ID=15843333

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP92914381A Withdrawn EP0603393A4 (fr)	1991-07-08	1992-07-06	Interleukine 6 humaine de recombinaison avec terminaison n homogene et production de cette interleukine.

Country Status (3)

Country	Link
EP (1)	EP0603393A4 (fr)
CA (1)	CA2113076A1 (fr)
WO (1)	WO1993001214A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR048335A1 (es)	2004-03-24	2006-04-19	Chugai Pharmaceutical Co Ltd	Agentes terapeuticos para trastornos del oido interno que contienen un antagonista de il- 6 como un ingrediente activo
CN106478774B (zh) *	2015-08-25	2021-09-14	三生国健药业（上海）股份有限公司	一种用于蛋白质表达的信号肽

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH03130088A (ja) *	1989-07-21	1991-06-03	Ajinomoto Co Inc	組み替えｄｎａ法によるポリペプチドの製造法

1992
- 1992-07-06 CA CA 2113076 patent/CA2113076A1/fr not_active Abandoned
- 1992-07-06 EP EP92914381A patent/EP0603393A4/fr not_active Withdrawn
- 1992-07-06 WO PCT/JP1992/000849 patent/WO1993001214A1/fr not_active Ceased

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH03130088A (ja) *	1989-07-21	1991-06-03	Ajinomoto Co Inc	組み替えｄｎａ法によるポリペプチドの製造法

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
HASEGAWA MASAKUZU ET AL: "Improvement in the heterogeneous N-termini and the defective N-glycosylation of human interleukin-6 by genetic engineering", EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 210, no. 1, November 1992 (1992-11-01), pages 9 - 12 *
MUNEHIRO NODA ET AL: "Purification and characterization of human fibroblast derived differentiation inducing factor for human monoblastic leukemia cells identical to interleukin-6", ANTICANCER RESEARCH, vol. 11, no. 2, March 1991 (1991-03-01), pages 961 - 968 *
NAOTO TONOUCHI ET AL: "High-level expression of human BSF-2/IL-6 cDNA in Escherichia coli using a new type of expression-preparation system", JOURNAL OF BIOCHEMISTRY, vol. 104, no. 1, 1988, TOKYO JP, pages 30 - 34 *
PATENT ABSTRACTS OF JAPAN vol. 15, no. 337 (C - 0862) 27 August 1991 (1991-08-27) *
See also references of WO9301214A1 *

Also Published As

Publication number	Publication date
CA2113076A1 (fr)	1993-01-21
EP0603393A1 (fr)	1994-06-29
WO1993001214A1 (fr)	1993-01-21

Similar Documents

Publication	Publication Date	Title
AU627099B2 (en)	1992-08-13	Process for the production of antibodies
ES8402351A1 (es)	1984-02-01	Procedimiento para producir interferon inmune humano.
BG60108B2 (bg)	1993-10-29	Метод за получаване на микробиална фитаза
KR920000789A (ko)	1992-01-29	면역글로불린 부분을 갖는 융합 단백질, 이의 제조방법 및 용도
DK0815245T3 (da)	2008-07-21	Bioaktive IL 12 fusionsproteiner
DE69638314D1 (de)	2011-02-03	Zirkuläres DNA Molekül mit einem abhängigen Replikationsursprung, seine Herstellungsverfahren und seine Verwendung in der Gentherapie
AR248044A1 (es)	1995-05-31	Una secuencia de adn que codifica anticuerpos monoclonales humanizados contra interleuquinas humanas, metodo de obtencion y de seleccion de dichos anticuerpos, vector recombinante y celula huesped.
SE8107812L (sv)	1982-07-01	Rekombinerade dna-molekyler och forfaranden for framstellning av proteiner
HUP9900768A2 (hu)	1999-06-28	Photorhabdusból származó inszekticid protein toxinok
DE122004000009I1 (de)	2004-11-18	Methode zur Herstellung von menschlichen Wachstumshormonen.
UA27035C2 (uk)	2000-02-28	Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
NO885555L (no)	1989-01-11	Produksjon av renset, biologisk aktivt, bakterielt produsert rekombinant humant csf-1.
SE8801701D0 (sv)	1988-05-05	Production technology based on enzymic method
DE69126049D1 (de)	1997-06-19	Vektoren und Zusammensetzungen zur Expression von Glykosilationsmutanten des menschlichen Proteins-C
EP0592566A4 (fr)	1995-05-24	Muteines d'il-6 depourvues de cysteine-------------.
ES2074046T5 (es)	2002-11-16	Procedimiento de construccion de una linea celular animal para la preparacion de beta-interferon humano.
KR870000356A (ko)	1987-02-18	메티오닐 단백질로부터 n-말단 메티오닌을 제거하는 방법
ATE239494T1 (de)	2003-05-15	Heparin-binding protein zur behandlung von sepsis
ZA916171B (en)	1992-04-29	Protein structure of the plant toxin gelonin
EP0603393A4 (fr)	1995-03-29	Interleukine 6 humaine de recombinaison avec terminaison n homogene et production de cette interleukine.
DK292584A (da)	1984-12-16	Biologisk aktive konjugater, deres fremstilling og anvendelse
DE69328437D1 (de)	2000-05-25	Interleukine-6 Mutante mit verbesserter biologischer Aktivität im vergleich zu wildtyp IL-6
DK100888A (da)	1988-10-28	Fremgangsmaade til at rense rekombinant pres-1/s-2/s hepatitis b antigen fra gaer
EP0497911A4 (en)	1992-12-16	Recombinant production of lactoperoxidase
NO174474C (no)	1998-06-09	FremgangsmÕte til fremstilling av et antibiotisk kedarcidin, samt en biologisk ren kultur av streptoalloteichus L585-6, ATCC 53650

Legal Events

Date	Code	Title	Description
1994-05-12	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1994-06-29	17P	Request for examination filed	Effective date: 19940201
1994-06-29	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE
1995-03-22	RHK1	Main classification (correction)	Ipc: C12N 15/24
1995-03-29	A4	Supplementary search report drawn up and despatched	Effective date: 19950208
1995-03-29	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE
1997-01-08	17Q	First examination report despatched	Effective date: 19961125
1997-08-22	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
1997-10-08	18D	Application deemed to be withdrawn	Effective date: 19970408